ADPT — Adaptive Biotechnologies Share News
0.000.00%
Last trade - 00:00- $4.08bn
- $4.08bn
- $276.98m
Brief: Adaptive Biotechnologies Announces Preliminary Fourth Quarter And Full Year 2025 Results
Brief: Adaptive Biotechnologies Corp - Unit Held Initial Closing $15 Million Series A Financing - SEC Filing
Brief: Adaptive Biotechnologies Signs Two Immune Receptor Licensing Deals With Pfizer
Adaptive signs deal with Pfizer worth up to $890 million for rheumatoid arthritis research (updated)
Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million
U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin Corp, Centuri Holdings
Adaptive Biotechnologies Q3 revenue surges above estimates on MRD business growth
Brief: Adaptive Biotechnologies Q3 EPS USD 0.06
Adaptive Biotechnologies Corp reports results for the quarter ended June 30 - Earnings Summary
Brief: Adaptive Biotechnologies Q2 EPS USD -0.17
U.S. RESEARCH ROUNDUP-American Tower, GoDaddy, Labcorp
Adaptive Biotechnologies rises after quarterly sales beat
Adaptive Biotechnologies Corp reports results for the quarter ended March 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Edison International, Onestream, Vertex Pharmaceuticals
Adaptive Biotechnologies Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Adaptive Biotechnologies Q4 EPS USD -0.23
Brief: Adaptive Biotechnologies Corp And Neogenomics Announce Strategic Collaboration
Brief: Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting
U.S. RESEARCH ROUNDUP- Akamai Technologies, Bill Holdings, Veeva Systems